Table Of Contents

1. Introduction 35
1.1. Overview Of Europe Drug Delivery Market 35
1.2. Currency And Pricing 36
1.3. Limitation 36
1.4. Markets Covered 36
2. Market Segmentation 38
2.1. Markets Covered 38
2.2. Geographic Scope 39
2.3. Years Considered For The Study 40
2.4. Currency And Pricing 40
2.5. Research Methodology 41
2.6. Primary Interviews With Key Opinion Leaders 44
2.7. Secondary Sources 45
2.8. Assumptions 45
3. Market Overview 46
3.1. Drivers 47
3.1.1. Rising Prevalence Of Chronic Diseases 47
3.1.2. Growth In The Development Of Biologics 47
3.1.3. Technological Development 48
3.2. Restraints 49
3.2.1. Risk Of Needle-Stick Injuries And Side Effects 49
3.3. Opportunities 50
3.3.1. Rising Acceptance Of Self Administering Drugs 50
3.3.2. Rising Demand For Biosimilars And Generic Drugs 51
3.3.3. Trend Of Merger And Acquisitions, And Collaborations 52
3.3.4. Focus On Patient Needs 52
3.3.5. Developing And New Emerging Revenue Pockets 53
3.4. Threats 54
3.4.1. Product Recalls 54
3.4.2. Stringent Regulatory And High Pricing 55
3.4.3. Patent Expiry And Patent Cliff 55
4. Executive Summary 57
5. Premium Insights 60
6. Europe Drug Delivery Market, By Route Of Administration 63
6.1. Overview 64
6.2. Europe Oral Drug Delivery Market, By Product Type 66
6.2.1. Europe Solid Oral Drug Delivery Market, By Product Type 67
6.2.2. Europe Liquid Oral Drug Delivery Market, By Product Type 69
6.2.3. Europe Semi-Solid Oral Drug Delivery Market, By Product Type 70
6.3. Europe Pulmonary Drug Delivery Market, By Product Type 76
6.3.1. Europe Nebulizers Market, By Product Type 78
6.4. Europe Injectable Drug Delivery Market, By Product Type 80
6.4.1. Europe Injectable Drug Delivery Devices, By Product Type 81
6.4.2. Europe Conventional Injectable Drug Delivery Devices Market 82
6.4.3. Europe Self-Injection Drug Delivery Devices Market, By Product Type 86
6.4.4. Europe Injectable Drug Delivery Formulations Market, By Product Type 89
6.5. Europe Ophthalmic Drug Delivery Market, By Product Type 92
6.5.1. Europe Ocuular Drug Delivery Formulations Market, By Form 93
6.5.2. Europe Occular Drug Delivery Devices, By Product Type 96
6.6. Europe Nasal Drug Delivery Market, By Product Type 98
6.7. Europe Topical Drug Delivery Market, By Product Type 100
6.7.1. Europe Transdermal Drug Delivery Devices Market, By Product Type 101
6.7.2. Europe Topical Drug Delivery Formulations Market, By Product Type 102
6.7.2.1. Europe Semi Solid Topical Drug Delivery Formulations Market, By Type 103
6.7.2.2. Europe Liquid Topical Drug Delivery Formulations Market, By Type 105
6.7.2.3. Europe Solid Topical Drug Delivery Formulations Market, By Type 106
6.8. Europe Implantable Drug Delivery Market, By Product Type 108
6.9. Europe Transmucosal Drug Delivery Market, By Product Type 110
6.9.1. Europe Oral Transmucosal Drug Delivery Market, By Product Type 111
6.9.2. Europe Oral Transmucosal Drug Delivery Market, By Product Type 113
7. Europe Drug Delivery Market, By Distribution Channel 115
7.1. Overview 115
8. Europe Drug Delivery Devices Market, By End User 117
8.1. Overview 118
9. Europe Drug Delivery Market, By Geography 121
9.1. Overview 121
9.2. Europe Drug Delivery Market 122
9.3. Germany Drug Delivery Market 143
9.4. U.K. Drug Delivery Devices Market 161
9.5. France Drug Delivery Market 179
9.6. Italy Drug Delivery Devices Market 197
9.7. Russia Drug Delivery Devices Market 215
9.8. Turkey Drug Delivery Market 233
9.9. Switzerland Drug Delivery Market 250
9.10. Belgium Drug Delivery Devices Market 268
9.11. Spain Drug Delivery Devices Market 285
9.12. Netherlands Drug Delivery Market 303
10. Rest Of Europe Drug Delivery Market 321
11. Europe Drug Delivery Market, Company Share 323
11.1. Company Share Analysis; Europe 323
12. Company Profiles 324
12.1. Johnson & Johnson 324
12.1.1. Company Overview 324
12.1.2. Revenue Analysis 325
12.1.3. Product Portfolio 326
12.1.4. Recent Developments 327
12.2. Pfizer, Inc. 330
12.2.1. Company Overview 330
12.2.2. Revenue Analysis 330
12.2.3. Product Portfolio 331
12.2.4. Recent Developments 337
12.3. 3M 341
12.3.1. Company Overview 341
12.3.2. Revenue Analysis 341
12.3.3. Product Portfolio 342
12.3.4. Recent Developments 342
?
12.4. Antares Pharma, Inc. 343
12.4.1. Company Overview 343
12.4.2. Revenue Analysis 343
12.4.3. Product Portfolio 344
12.4.4. Recent Developments 344
12.5. Merck & Co. 346
12.5.1. Company Overview 346
12.5.2. Revenue Analysis 346
12.5.3. Product Portfolio 347
12.5.4. Recent Developments 348
13. Related Reports 352